Who owns Fulcrum Therapeutics Inc?
- Ticker: FULC
- CUSIP Number: 359616109
Tip: Access positions for across all investors
Analyze quarterly positions in Fulcrum Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Fulcrum Therapeutics stock
Who bought or sold Fulcrum Therapeutics Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
RA Capital Management | 12M | $78M | 0% | Dec 2023 |
|
Cowen And Company | 3.5M | $23M | -19% | Dec 2023 |
|
Vanguard Group | 2.5M | $17M | -5% | Dec 2023 |
|
Trv Gp Iv | 2.3M | $16M | 0% | Dec 2023 |
|
Citadel Advisors | 1.7M | $12M | 8% | Dec 2023 |
|
Logos Global Management | 1.2M | $8.1M | 100% | Dec 2023 |
|
Dimensional Fund Advisors | 975k | $6.6M | 74% | Dec 2023 |
|
Goldman Sachs Group | 872k | $5.9M | 236% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 823k | $5.6M | 100% | Dec 2023 |
|
Propel Bio Management | 750k | $5.1M | 100% | Dec 2023 |
|
ADAR1 Capital Management | 637k | $4.3M | 100% | Dec 2023 |
|
Simplify Asset Management | 563k | $3.8M | -1% | Dec 2023 |
|
Marshall Wace | 505k | $3.4M | -52% | Dec 2023 |
|
D. E. Shaw & Co | 498k | $3.4M | 125% | Dec 2023 |
|
Two Sigma Advisers | 496k | $3.3M | -5% | Dec 2023 |
|
Millennium Management | 438k | $3.0M | -56% | Dec 2023 |
|
Schonfeld Strategic Advisors | 433k | $2.9M | 100% | Dec 2023 |
|
Jane Street | 347k | $2.3M | 801% | Dec 2023 |
|
Bessemer | 287k | $1.9M | 0% | Dec 2023 |
|
Citigroup | 285k | $2.0M | 220% | Dec 2023 |
|
Two Sigma Investments | 262k | $1.8M | -53% | Dec 2023 |
|
Standard Life Aberdeen | 257k | $1.7M | 100% | Dec 2023 |
|
Alliancebernstein | 240k | $1.6M | 3% | Dec 2023 |
|
Partners HealthCare System | 205k | $1.9M | 100% | Mar 2024 |
|
Alyeska Investment Group | 202k | $1.4M | 0% | Dec 2023 |
|
Bank of America Corporation | 188k | $1.3M | 35% | Dec 2023 |
|
Laurion Capital Management | 145k | $977k | 100% | Dec 2023 |
|
Fiduciary Trust Company | 137k | $922k | 0% | Dec 2023 |
|
Acuitas Investments | 135k | $910k | 0% | Dec 2023 |
|
Opaleye Management | 130k | $878k | 100% | Dec 2023 |
|
Jacobs Levy Equity Management | 122k | $824k | -54% | Dec 2023 |
|
Balyasny Asset Management | 105k | $710k | 100% | Dec 2023 |
|
Commonwealth Equity Services | 96k | $651k | 100% | Dec 2023 |
|
Man Group | 95k | $639k | 100% | Dec 2023 |
|
Stifel Financial | 72k | $482k | 158% | Dec 2023 |
|
Barclays | 68k | $460k | 100% | Dec 2023 |
|
Landscape Capital Management | 65k | $437k | 129% | Dec 2023 |
|
DekaBank Deutsche Girozentrale | 60k | $568k | 0% | Mar 2024 |
|
683 Capital Management | 47k | $316k | 100% | Dec 2023 |
|
ALPS Advisors | 40k | $269k | 100% | Dec 2023 |
|
Wolverine Trading | 35k | $239k | 127% | Dec 2023 |
|
Simplex Trading | 31k | $290k | 100% | Mar 2024 |
|
Country Trust Bank | 30k | $285k | 0% | Mar 2024 |
|
UBS Group | 30k | $204k | 171% | Dec 2023 |
|
Marquette Asset Management | 28k | $188k | 0% | Dec 2023 |
|
Denali Advisors | 27k | $256k | -53% | Mar 2024 |
|
Algert Coldiron Investors | 26k | $174k | -17% | Dec 2023 |
|
Brown Wealth Management | 25k | $169k | 0% | Dec 2023 |
|
Franklin Resources | 25k | $168k | -12% | Dec 2023 |
|
Charles Schwab Investment Management | 25k | $165k | 0% | Dec 2023 |
|
Blackstone Group | 19k | $130k | 0% | Dec 2023 |
|
Principal Financial Group | 18k | $122k | -4% | Dec 2023 |
|
Mirabella Financial Services | 17k | $114k | 100% | Dec 2023 |
|
LM Advisors | 16k | $109k | 100% | Dec 2023 |
|
T. Rowe Price Associates | 16k | $108k | 0% | Dec 2023 |
|
Alphabet | 14k | $96k | 0% | Dec 2023 |
|
Bank Of Montreal | 14k | $98k | 100% | Dec 2023 |
|
Sherbrooke Park Advisers | 12k | $79k | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 11k | $77k | 5% | Dec 2023 |
|
Capstone Investment Advisors | 10k | $68k | 100% | Dec 2023 |
|
China Universal Asset Management | 7.2k | $48k | 349% | Dec 2023 |
|
PrairieView Partners | 5.0k | $34k | 0% | Dec 2023 |
|
Aquatic Capital Management | 4.2k | $28k | 100% | Dec 2023 |
|
Zurcher Kantonalbank | 2.5k | $23k | 23% | Mar 2024 |
|
Rhumbline Advisers | 1.7k | $11k | 0% | Dec 2023 |
|
NISA Investment Advisors | 1.5k | $10k | 0% | Dec 2023 |
|
BFSG | 1.2k | $11k | 100% | Mar 2024 |
|
Steward Partners Investment Advisory | 790.00 | $5.3k | 0% | Dec 2023 |
|
National Bank Of Canada /fi/ | 460.00 | $3.3k | 0% | Dec 2023 |
|
Wells Fargo & Company | 381.00 | $2.6k | 6% | Dec 2023 |
|
Daiwa Securities Group | 138.00 | $1.0k | 0% | Dec 2023 |
|
GAMMA Investing | 45.00 | $424.998000 | 100% | Mar 2024 |
|
Parallel Advisors | 44.00 | $297.000000 | 100% | Dec 2023 |
|
Royal Bank of Canada | 8.00 | $0 | -20% | Dec 2023 |
|
Who sold out of Fulcrum Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Hudson Bay Capital Management | Sep 2023 | 197k | $872k |
Jump Financial | Sep 2023 | 92k | $408k |
Occudo Quantitative Strategies | Sep 2023 | 87k | $388k |
Squarepoint Ops | Sep 2023 | 59k | $262k |
Bank of New York Mellon | Dec 2023 | 20k | $134k |
Graham Capital Management | Sep 2023 | 12k | $53k |
Centiva Capital | Sep 2023 | 11k | $48k |